Infectious Disease Control
ScentAir Steps Up Efforts to Address Customers' Concern Over Air Quality
HONG KONG, May 26, 2022 /PRNewswire/ -- ScentAir, the scent marketing leader,
continues to lead the way in helping brands globally address customers'
concerns, as cases surge inChina amid lockdowns.
2022-05-26 17:26
4966
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic
Includes asymptomatic testing at community-based facilities to prevent widespread transmissions Regular testing for COVID-19, flu, RSV crucial for staying safe as anti-virus restrictions are eased PCR tests will be priced affordably, made possible through Seegene's 20 years of expertise "Full ...
2022-05-25 19:00
2835
Brii Biosciences to be Added to MSCI China Small Cap Index
DURHAM, N.C. and BEIJING, May 25, 2022 /PRNewswire/ -- Brii Biosciences Limited
2022-05-25 08:00
5793
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment
* Insilico's candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for co-administration with Ritonavir. * The candidate is intended to be used for the treatment of SARS-CoV-2 and its variants, along with other coronaviruses. Insi...
2022-05-24 21:00
3320
New Study Shows Critical Role of 1,5-Anhydroglucitol (1,5-AG) in COVID-19 Pathogenesis by Binding to the COVID-19 Spike Protein
Study Findings Support Data Presented on the GlycoMark Blood Test at the Most RecentADA and AHA Scientific Sessions RALEIGH, N.C., May 24, 2022 /PRNewswire/ -- Precision Diabetes, Inc. A new study recently published inNature Metabolism shows that 1,5-anhydroglucitol (1,5-AG), a glucose-like me...
2022-05-24 19:00
1943
CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing
TIANJIN, China, May 19, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced that the World Health Organization ("WHO") has granted Emergency Use Listing ("EUL") for Convidecia™, CanSinoBIO's Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5...
2022-05-19 23:28
4559
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding
BOSTON, May 19, 2022 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration with the National Institutes of Health to develop small molecule antiviral therapeutics to prevent pandemics. The cente...
2022-05-19 04:56
4407
SIMCERE PHARMA (HK.2096) Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China
HONG KONG, May 18, 2022 /PRNewswire/ -- SIMCERE PHARMA (HK.2096) announced that SIM0417, a candidate drug against SARS-Cov-2, for which the Company holds license from Shanghai Institute ofMateria Medica (SIMM) and Wuhan Institute of Virology, Chinese Academy of Sciences, has obtained the Clinica...
2022-05-18 11:56
2657
ASEAN to build its own CDC to mitigate another pandemic risk
DENPASAR, Indonesia, May 18, 2022 /PRNewswire/ -- ASEAN members agreed on
setting up the ASEAN Center for Public Health Emergencies and Emerging Diseases
(ACPHEED) at the 15th ASEAN Health Minister Meeting (15th AHMM) inNusa Dua,
Bali, Indonesia on May 11-15, 2022.
2022-05-18 09:00
4089
ASEAN accepts mutually recognized COVID-19 vaccination certificates
DENPASAR, Indonesia, May 17, 2022 /PRNewswire/ -- ASEAN Member States collectively recognize the COVID-19 vaccination certificate to be applied in Southeast Asia. Health Ministers of ASEAN countries endorsed the decision during the 15th ASEAN Health Ministers Meeting (15th AHMM) inNusa Dua, Bali, ...
2022-05-17 19:14
2690
NEW GUIDELINES FOR COVID TESTING
A new ISO technical specification will improve testing procedures and contribute to a safer world. SHENZHEN, China, May 13, 2022 /PRNewswire/ -- The COVID pandemic first reared its head in 2019 and despite concerted efforts from authorities and the public, it's still with us. Dedicated stan...
2022-05-13 17:10
2603
ECCMID 2022: Copan unveils its WISE approach to sample management
BRESCIA, Italy, May 12, 2022 /PRNewswire/ -- Copan took the chance of the first in-person ECCMID of the last two years to give a name to itsholistic approach to preanalytics. From sample collection to image analysis and data interpretation, meet Copan's WISE approach, which brings any sample to i...
2022-05-12 20:25
2846
HKBN Receives Amazon Web Services' HK Managed Service Award
Cloud technology enhances scalability and flexibility HONG KONG, May 11, 2022 /PRNewswire/ -- HKBN Enterprise Solutions ("HKBN") is awardedAmazon Web Services' ("AWS") Managed Service Provider Partner of the Year . With the largest number of AWS certifications inHong Kong, HKBN is actively embrac...
2022-05-11 11:49
3740
U.S. Centers for Disease Control and Prevention Selects Biobot Analytics to Expand National Wastewater Monitoring
CAMBRIDGE, Mass., May 10, 2022 /PRNewswire/ -- The U.S. Centers for Disease Control (CDC) has selected Biobot Analytics to expand the agency's National Wastewater Surveillance System (NWSS), an integral part of President Biden's plan to fight Covid-19 and prepare the country for future pandemics....
2022-05-10 00:00
3381
Brii Bio Reports Progress on ESG Commitments in Its Inaugural ESG Report
DURHAM, N.C. and BEIJING, May 7, 2022 /PRNewswire/ -- Brii Biosciences Limited
2022-05-07 09:00
6163
SICPA AND THE BATAILLON DE MARINS-POMPIERS DE MARSEILLE ARE TESTING AN INNOVATIVE SOLUTION FOR DETECTING PATHOGENS IN AIRCRAFT WASTEWATER
Authorities can rely on a robust decision-making tool to strengthen their fight against the COVID-19 pandemic and future health risks. LAUSANNE, Switzerland, May 6, 2022 /PRNewswire/ -- The Swiss company SICPA, a world leader in identification, traceability and authentication technologies, and t...
2022-05-06 14:00
5796
Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama
FREDERICK, Md., April 29, 2022 /PRNewswire/ -- Healion Bio, a closely held biotechnology company, today announced a collaborative agreement to research a combination antiviral against SARS-CoV-2 and other deadly pathogens. The combination will include one of Healion Bio's protease inhibitors and ...
2022-04-29 01:00
2703
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
AUSTIN, Texas, April 27, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV ...
2022-04-27 00:09
3355
The First International COVID-19 Testing Standard Released
BEIJING, April 26, 2022 /PRNewswire/ -- According to the State Administration for Market Regulation, the International Organization for Standardization (ISO) released the first international standard specifically for the detection of SARS-CoV-2, the virus that causes COVID-19. On April 19, ISO i...
2022-04-26 13:02
1643
Confusing health requirements are stopping passengers from flying
An international survey of people in the United States, the United Kingdom, Italy, and the Gulf reveals widespread confusion around health requirements for air travel, and fears that the aviation sector is not prepared for another global health crisis * Many people in every country surveyed sa...
2022-04-22 02:45
5635
Week's Top Stories
Most Reposted
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 328 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 310 media titles]
2026-02-26 19:57
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 309 media titles]
2026-02-26 09:30
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 302 media titles]
2026-02-24 16:13
Most Read
NYSE Content Update: AI Data Platform DDN Appoints Guido Torrini as Finance Chief
2026-02-24 22:08
5636
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
2026-02-23 08:00
5058
Newmark Appoints Shanting Wong as Head of Research in Singapore
2026-02-25 09:00
4976
